Kyowa Hakko USA Highlights Branded Ingredients and New Innovations at SupplySide West 2022
Kyowa Hakko USA at SupplySide West 2022 Booth# 3065 will Feature events for IMMUSE™ and Cognizin®
NEW YORK, Nov. 1, 2022 /PRNewswire-PRWeb/ -- Kyowa Hakko USA, leading international health ingredient manufacturer and world leader in the development, manufacturing, and marketing of pharmaceuticals, nutraceuticals and food products, announces featured events for IMMUSE™ a postbiotic that delivers a new, breakthrough approach to more comprehensive immune support* and Cognizin® Citicoline, a clinically studied and branded form of Citicoline.
IMMUSE™:
Wednesday, November 2, 2022 – 11:30 am - 12:20 pm, at Supplier Theater #3677
Heather Moday, MD, author of "The Immunotype Breakthrough," will be speaking about "Building Immune Resilience Using Our Personal Immunotype," and she will also discuss the novel postbiotic IMMUSE™ and its mode of action in providing more comprehensive immune support. The audience will be able to determine their own personal immunotype as Dr. Moday leads the discussion on how to balance the immune system.
Following the presentation, Dr. Moday will be at the Kyowa Hakko Booth # 3065 starting at 1:00 pm to sign her recent book, The Immunotype Breakthrough. Press is invited to stop by.
As a clinically researched immune activator* supported by 29 published studies, including 14 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells)*. The pDC, a rare type of immune cell, functions as a key leader of the immune system and has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko's parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.
Cognizin® Citicoline "Tap Challenge":
The "Tap Challenge" app tests how quickly an individual can tap a button in 20 seconds. Great for training reflexes for more complex fighter games and games that need quick combinations, Tap Challenge truly gets your fingers moving. It looks simple but tapping with one finger, even for 20 seconds, is not that easy. Players can download the app from a QR code at the Kyowa Hakko booth and practice their tapping skills before facing off against the highest scorers at the show.
Qualifying rounds are on:
Wednesday Nov 2: 2:00pm – 4:00 pm
Thursday Nov 3: 10:00am – 11:30 am
At noon on Thursday, the players with the top 5 scores will tap off against each other to win Amazon Gift Cards!
1st Place: $250 Amazon Gift Card
2nd Place: $100 Amazon Gift Card
3rd Place: $50 Amazon Gift Card
"When we first debuted the test version at SxSW Gaming Expo in 2019, the response was overwhelming. So, we decided to make it available to everyone interested in powering their game," commented Karen Todd, MBA, RD, Vice President Global Brand Marketing, Kyowa Hakko USA, Inc.
This all began following the results of a study that Kyowa Hakko initiated in 2015. Using a Finger Tap Test, the results supported improved attentional abilities, psychomotor speed and inhibition in healthy adolescent males when supplementing with Cognizin® Citicoline over a 30-day period (McGlade, et al., 2015). The double-blinded study was conducted by neuropsychologists using a variety of tests that simulated cognitive functions and keyboard actions like those exercised in PC video games.
An innovative form of citicoline, a potent brain-health nutrient and nootropic, Cognizin® has been extensively clinically studied to support mental energy, focus, memory, and attention*. Many other cognitive health ingredients only enhance brain performance. Cognizin® provides more comprehensive brain health support over time for gamers and anyone interested in supporting their overall cognitive health*.
*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.
About IMMUSE™:
IMMUSE™ is a postbiotic that delivers a new, breakthrough approach to broad range immune support*. As a clinically researched immune activator* supported by over 29 published studies, including 14 human trials, IMMUSE™ proactively supports the immune system through a novel method of action that activates pDC (plasmacytoid dendritic cells) *. The pDC, a rare type of immune cell, functions as the key leader of the immune system and has been shown to activate pivotal cells, such as NK, Killer-T, Helper-T, and B cells, for a more comprehensive approach to immune support*. Its unique mechanism of action, discovered by Kyowa Hakko's parent company Kirin Holdings Co., Ltd., is opening doors for discovering postbiotics concerning immune health.
About Cognizin® Citicoline
Cognizin® Citicoline, manufactured by Kyowa Hakko Bio Co., Ltd., is a clinically studied and branded form of Citicoline, a natural substance made endogenously in the body and especially vital to brain health.* Citicoline is a potent brain-health nutrient. A proprietary form of citicoline, Cognizin® has been clinically studied to support mental energy, focus, attention, and memory. Cognizin® is manufactured through a fermentation process to yield high quality and high purity. Cognizin® is also highly stable, GRAS, pure and allergen-free. Cognizin® is available in over 200 products. For more information on Cognizin®, visit Cognizin.com.
About Kyowa Hakko USA:
Kyowa Hakko USA is the North & South American office for Kyowa Hakko Bio Co. Ltd., an international health ingredients manufacturer and world leader in the development,
manufacturing, and marketing of pharmaceuticals, nutraceuticals, and food products. For more information, visit Kyowa-USA.com.
Media interested in setting up an interview with Heather Moday MD, or Karen Todd, please drop by the Kyowa Hakko booth # 3065 or call Sue Taggart at 917.833.8101.
Media Contact
Maria Stanieich, Kyowa Hakko, 5514829968, [email protected]
SOURCE Kyowa Hakko
Share this article